AGP Executive Report
Last update: 7 hours agoCancer Drug Costs: India’s NPPA capped trade margins at 30% on 137 commonly used cancer drugs, with revised prices taking effect Nov. 9; Keytruda is excluded. Health Workforce: Nepal added 418 government medical-education seats, including 110 for medical degrees and 210 for nursing. Industry Safety: A fire broke out in the herbal division of a medicine factory in Bangladesh; no injuries were reported initially. Infectious Disease: US measles cases reached 4,410, including five confirmed deaths in Pennsylvania, while WHO urged vigilance after a second Ebola case in Kenya. Treatment Advances: EU regulators backed Foundayo, an oral medicine for obesity and type 2 diabetes. In a small trial, a long-acting HIV drug combination kept all 46 participants virally suppressed. Care Access: New findings suggest glucose monitors may benefit people with type 2 diabetes who do not use insulin.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[ The Unique Considerations Mid-Sized Pharma Companies Face When Making MFN Deals]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/29479793-950169651-30e8073b2dc0176507c7f29f8a3546cb19aa3b7a-1280x720-200x113.jpeg)
